Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2017 4
2018 3
2019 2
2020 3
2021 3
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Top ten errors of statistical analysis in observational studies for cancer research.
Carmona-Bayonas A, Jimenez-Fonseca P, Fernández-Somoano A, Álvarez-Manceñido F, Castañón E, Custodio A, de la Peña FA, Payo RM, Valiente LP. Carmona-Bayonas A, et al. Among authors: alvarez mancenido f. Clin Transl Oncol. 2018 Aug;20(8):954-965. doi: 10.1007/s12094-017-1817-9. Epub 2017 Dec 7. Clin Transl Oncol. 2018. PMID: 29218627 Review.
Does active smoking worsen Covid-19?
Carmona-Bayonas A, Jimenez-Fonseca P, Sánchez Arraez Á, Álvarez Manceñido F, Castañón E. Carmona-Bayonas A, et al. Among authors: alvarez mancenido f. Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28. Eur J Intern Med. 2020. PMID: 32507518 Free PMC article.
Bayesian interpretation of immunotherapy trials with dynamic treatment effects.
Castañon E, Sanchez-Arraez Á, Jimenez-Fonseca P, Alvarez-Manceñido F, Martínez-Martínez I, Mihic Gongora L, Carmona-Bayonas A. Castañon E, et al. Among authors: alvarez mancenido f. Eur J Cancer. 2022 Jan;161:79-89. doi: 10.1016/j.ejca.2021.11.002. Epub 2021 Dec 18. Eur J Cancer. 2022. PMID: 34933154
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido F, Jimenez-Fonseca P, Carmona-Bayonas A, Arrazubi V, Hernandez R, Cano JM, Custodio A, Pericay Pijaume C, Aguado G, Martínez Lago N, Sánchez Cánovas M, Cacho Lavin D, Visa L, Martinez-Torron A, Arias-Martinez A, López F, Limón ML, Vidal Tocino R, Fernández Montes A, Alsina M, Pimentel P, Reguera P, Martín Carnicero A, Ramchandani A, Granja M, Azkarate A, Martín Richard M, Serra O, Hernández Pérez C, Hurtado A, Gil-Negrete A, Sauri T, Morales Del Burgo P, Gallego J. Alvarez-Manceñido F, et al. Gastric Cancer. 2021 Jul;24(4):926-936. doi: 10.1007/s10120-021-01169-6. Epub 2021 Mar 2. Gastric Cancer. 2021. PMID: 33651195
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Carmona-Bayonas A, et al. Among authors: alvarez mancenido f. Thromb Haemost. 2019 Nov;119(11):1849-1859. doi: 10.1055/s-0039-1694012. Epub 2019 Aug 28. Thromb Haemost. 2019. PMID: 31461750
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Carmona-Bayonas A, Jiménez-Fonseca P, Echavarria I, Sánchez Cánovas M, Aguado G, Gallego J, Custodio A, Hernández R, Viudez A, Cano JM, Martínez de Castro E, Macías I, Martín Carnicero A, Garrido M, Mangas M, Álvarez Manceñido F, Visa L, Azkarate A, Ramchandani A, Fernández Montes A, Longo F, Sánchez A, Pimentel P, Limón ML, Arias D, Cacho Lavin D, Sánchez Bayona R, Cerdá P, García Alfonso P; AGAMENON Study Group. Carmona-Bayonas A, et al. Among authors: alvarez mancenido f. Eur J Surg Oncol. 2018 Aug;44(8):1191-1198. doi: 10.1016/j.ejso.2018.03.019. Epub 2018 Mar 31. Eur J Surg Oncol. 2018. PMID: 29685755
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Arias-Martinez A, Martínez de Castro E, Gallego J, Arrazubi V, Custodio A, Fernández Montes A, Diez M, Hernandez R, Limón ML, Cano JM, Vidal-Tocino R, Macias I, Visa L, Martin Richard M, Sauri T, Hierro C, Gil M, Cerda P, Martínez Moreno E, Martínez Lago N, Mérida-García AJ, Gómez González L, García Navalón FJ, Ruiz Martín M, Marín G, López-López F, Ruperez Blanco AB, Fernández AF, Jimenez-Fonseca P, Carmona-Bayonas A, Alvarez-Manceñido F. Arias-Martinez A, et al. Among authors: alvarez mancenido f. Clin Transl Oncol. 2024 Feb 15. doi: 10.1007/s12094-024-03388-6. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38361134
Erratum to "Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings" [Eur J Cancer 136 (September 2020) 159-168].
Castañón E, Sanchez-Arraez A, Alvarez-Manceñido F, Jimenez-Fonseca P, Carmona-Bayonas A. Castañón E, et al. Among authors: alvarez mancenido f. Eur J Cancer. 2021 Jan;142:152-153. doi: 10.1016/j.ejca.2020.10.003. Epub 2020 Nov 5. Eur J Cancer. 2021. PMID: 33162285 No abstract available.
16 results